Glaucoma surgery recovery is quite different from recovery after cataract surgery. Following procedures such as trabeculectomy, PreserFlo or glaucoma tube surgery, vision is often blurred initially and the eye may take several weeks to settle. Just as importantly, the follow-up visits after surgery are an essential part of achieving a good result. If you’ve had cataract surgery, or you know someone who has, you probably have a certain picture in your head of what eye surgery looks like: a quick procedure, a slightly blurry day or two, and then noticeably better vision. You go in worse and come out better.
Filtration surgery for glaucoma — trabeculectomy, PreserFlo, or a tube implant (Paul tube or eyePlate S) — is a completely different kind of operation, and it’s important you understand that difference before you have it. If you walk in expecting a “glaucoma cataract surgery,” you will be disappointed, possibly frightened by a normal recovery, and less able to make good decisions about your own care afterwards.
This isn’t a scare piece. These operations are some of the most important I perform, and for the right patient at the right time, they are vision-saving. But they deserve an honest account of what they actually do, what they cost you, and what “success” really means — because the version you’ll find in a pamphlet or a journal abstract is often not the version that matters to you.
The goal is different: protecting, not improving
Cataract surgery removes a cloudy lens and replaces it with a clear one. The eye gets better. Filtration surgery does not make your eye see better. At best, it stops your eye getting worse. Your vision on the day after surgery — assuming no complications — is usually the best it is ever going to be from that point onward. Success is measured in vision not lost over the following years and decades, which is a much harder thing to feel grateful for in the moment.
This matters because glaucoma damage is invisible and painless until it isn’t. You may be reading this with vision that feels completely normal to you, because your peripheral field has been slowly narrowing for years without you noticing — that’s simply how glaucoma behaves. Surgery is recommended because I can see, on your visual fields and your optic nerve imaging, that the trajectory you’re on will eventually take central vision from you if we don’t intervene more aggressively. The operation isn’t fixing something you can feel is broken. It’s stopping a slow process you can’t feel happening at all.
That asymmetry — real surgical risk and recovery, for a benefit you can’t directly perceive — is the single hardest thing about counselling patients for this surgery, and it’s worth sitting with before you consent to it.
The compromises
Every filtration procedure works by creating a new drainage pathway for fluid to leave the eye, bypassing the eye’s own blocked or inefficient drainage system. That new pathway is a genuine anatomical change to your eye, and it comes with trade-offs that cataract surgery simply doesn’t have:
- A bleb or plate under the conjunctiva. With trabeculectomy or PreserFlo, fluid drains into a reservoir under the surface of your eye — the bleb. It can be visible, especially early on, and it changes the feel of the eye (a mild foreign-body sensation is common). With a tube, a plate sits further back under the conjunctiva and is generally less visible, but it’s still a permanent implant.
- A more fragile eye. Filtering surgery deliberately creates a lower-resistance drainage path. That’s the whole point — but it also means the eye’s pressure can swing more than a normal eye’s, particularly in the first weeks, and the surgical site needs a degree of ongoing respect (avoiding eye rubbing, contact sports without protection, and so on) for the rest of your life.
- A longer, more demanding recovery. Cataract recovery is measured in days. Filtration surgery recovery is measured in months — frequent early reviews (sometimes weekly), a longer course of drops, and a real chance of needing procedures at the slit lamp (needling, suture removal or laser suture lysis, injections) in the first few months to shape how the drainage settles.
- A small but real chance vision is worse afterwards, not from the glaucoma but from the surgery itself — through low pressure (hypotony), bleeding, infection, or cataract progression (in a phakic eye). I’ll come back to this below, but it needs to be said plainly here: this is a real operation on the eye, and real operations carry real risk.
None of this is a reason not to have the surgery when it’s indicated. It’s the reason to be clear-eyed about what you’re signing up for.
The number in the paper isn’t the number in your chart
Here is the point I most want you to understand, because it causes more confusion than anything else in glaucoma surgery.
If you read the published literature on trabeculectomy, PreserFlo, or tube surgery, “success” is very often defined as an intraocular pressure (IOP) somewhere under 21mmHg, sometimes with a floor around 5-6mmHg to guard against the eye being too low. By that definition, a huge proportion of operations “succeed.”
But 21mmHg is not a target that means much to most of the patients I operate on. It was originally a population-average upper limit of “statistically normal” pressure — not a pressure that’s safe for an eye with established, often advanced, glaucomatous damage. Many of my patients need pressures in the low-to-mid teens, and a good number need pressures around 10-12mmHg to have a realistic chance of preserving the visual field they have left, particularly if the damage is already moderate to advanced or the optic nerve is especially vulnerable.
That gap matters enormously. An eye that settles at 19mmHg after surgery would be recorded as a “success” in most trial data. In a patient who needed to be at 11mmHg, that same result is a failure — the disease will very likely keep progressing, just more slowly than before. If I only ever quoted you trial “success rates,” I would be giving you a number that overstates how likely you are to get the outcome you actually need.
What I try to do instead — and what I’d encourage you to ask any surgeon — is talk in terms of:
- What target pressure is this eye likely to need, based on how advanced the damage already is and how it has behaved over time.
- What proportion of eyes like yours actually reach that specific target, not just the generic under-21 threshold.
- How that number changes with additional drops, laser, or a further procedure, since very few patients reach their true target on the operation alone, without any adjunct treatment at all.
By that more honest and more personal measure, success rates for reaching a genuinely low target pressure are meaningfully lower than the headline figures you’ll read elsewhere — and that’s precisely why this conversation, before surgery, matters so much. You deserve to consent to the real odds, not the flattering ones.
Further intervention is the rule, not the exception
Because of that gap between “under 21” and “the pressure you actually need,” it’s extremely common — not a sign that anything has gone wrong — for a filtration operation to be followed by:
- Bleb needling at the slit lamp, sometimes more than once, to keep a trabeculectomy or PreserFlo bleb draining well.
- Laser suture lysis or releasable suture removal in the early weeks to titrate flow.
- Restarting or adding pressure-lowering drops, even after a “successful” operation, to reach your specific target.
- Selective laser trabeculoplasty or other laser treatment to an eye that still has some function in its native drainage system.
- A second filtration procedure, at a different site or with a different technique, if the first bleb or tube fails to control pressure adequately over time — which happens for a meaningful minority of patients, sometimes years down the track.
None of these represent your surgery “not working.” They represent glaucoma being a chronic, progressive disease that is managed rather than cured, and a single operation being one tool in an ongoing process of keeping your pressure where it needs to be. I would rather you expect this from the outset than feel, three months after surgery, that something has gone wrong when I recommend a needling or restart a drop.
Complications: the honest list
I take these seriously enough that I want to name them directly rather than bury them in a consent form you sign on the day.
Early complications (days to weeks): hypotony (pressure too low, which can cause blurred vision, choroidal effusions, or shallowing of the front chamber of the eye), bleeding inside the eye, shallow or flat anterior chamber, and infection at or around the surgical site.
Later complications (months to years): bleb leak, bleb-related infection (blebitis or, rarely, endophthalmitis — a sight-threatening infection inside the eye, which is why any bleb-related eye becomes red, painful, or unusually light-sensitive needs to be seen urgently, for life), tube exposure or erosion through the conjunctiva, corneal decompensation from tube-cornea contact, double vision from the plate affecting eye movement, and cataract progression in an eye that still has its natural lens.
Vision loss directly caused by the surgery, rather than by the glaucoma, is uncommon but real — most often related to hypotony, bleeding, or infection. It’s precisely because these risks exist that filtration surgery is reserved for eyes where the risk of not operating — continued, uncontrolled progression toward blindness — is judged to be higher than the risk of the operation itself. That balance of risk is the actual clinical decision being made when I recommend surgery, and it’s one I make individually for your eye, not generically for “glaucoma.”
Not a cure — one step in a long journey
Filtration surgery does not cure glaucoma. There is currently no cure. What it does is lower your eye pressure — often substantially — to reduce the rate at which optic nerve damage progresses. Some patients need one operation and years of stability follow. Others need staged intervention over a lifetime: drops, laser, one filtration procedure, and later another, as the disease and the eye’s response to previous surgery evolve.
The right way to think about it is not “the operation that fixes my glaucoma” but “the next step that gives my optic nerve the best realistic chance, for as long as possible.” That reframing changes how you should judge the outcome. Six months after surgery, the right question isn’t “am I cured?” — it’s “is my pressure where it needs to be, and is my visual field stable?” If the answer is yes, the surgery has done exactly what it was meant to do, even if you’re still on a drop, even if you needed a needling, even if we’re already discussing what comes next.
So why do we do it?
Given everything above — no improvement in vision, real recovery burden, a genuine complication profile, a good chance of needing more procedures, and no cure at the end of it — it’s fair to ask why filtration surgery is worth doing at all.
The answer is the alternative. Left unchecked, glaucoma takes peripheral vision first, often so gradually it goes unnoticed, and can progress to take central vision and, eventually, sight itself. Drops and laser are the first and often adequate lines of treatment for many patients, but for eyes where pressure remains too high on maximum tolerated medical therapy, or where damage is progressing despite treatment, or where the starting pressure is so high that drops alone will never realistically reach a safe target — filtration surgery is often the only intervention capable of reaching the low pressures that eye actually needs.
I recommend it when I judge that the vision you have now — the vision you’re reading this with — is genuinely at risk without it. The trade-off is real surgery, real recovery, and an honest chance of further procedures down the track, in exchange for the best available chance of keeping the sight you still have. For the patients who need it, that trade-off is almost always the right one. My job is to make sure you’re making that decision with the real numbers, not the flattering ones — which is exactly why this article exists.
This article is general information and does not replace individual consultation. Your own risk profile, target pressure, and the most suitable procedure for your eye should always be discussed directly with your surgeon.